 Emily Sterbis
Concepts (62)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vena Cava Filters | 1 | 2023 | 64 | 0.720 |
Why?
| | Embolization, Therapeutic | 1 | 2022 | 242 | 0.630 |
Why?
| | Osteoarthritis, Knee | 1 | 2022 | 279 | 0.590 |
Why?
| | Knee Joint | 1 | 2022 | 426 | 0.570 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1180 | 0.390 |
Why?
| | Lung Neoplasms | 1 | 2022 | 2637 | 0.280 |
Why?
| | Neoplasms | 1 | 2023 | 2875 | 0.260 |
Why?
| | Watchful Waiting | 1 | 2023 | 89 | 0.180 |
Why?
| | Device Removal | 1 | 2023 | 143 | 0.170 |
Why?
| | Radiopharmaceuticals | 1 | 2022 | 194 | 0.170 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2022 | 156 | 0.170 |
Why?
| | Positron Emission Tomography Computed Tomography | 1 | 2022 | 117 | 0.170 |
Why?
| | Arteries | 1 | 2022 | 259 | 0.170 |
Why?
| | Positron-Emission Tomography | 1 | 2022 | 323 | 0.160 |
Why?
| | Arthritis, Infectious | 2 | 2018 | 72 | 0.160 |
Why?
| | Pain Management | 1 | 2022 | 405 | 0.140 |
Why?
| | Blood Loss, Surgical | 1 | 2018 | 112 | 0.130 |
Why?
| | Prosthesis-Related Infections | 1 | 2018 | 99 | 0.130 |
Why?
| | Pain | 1 | 2022 | 779 | 0.130 |
Why?
| | Retrospective Studies | 4 | 2023 | 17066 | 0.120 |
Why?
| | Warfarin | 1 | 2018 | 170 | 0.120 |
Why?
| | Medicare | 1 | 2022 | 886 | 0.120 |
Why?
| | Arthroplasty, Replacement, Knee | 2 | 2018 | 370 | 0.120 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2018 | 182 | 0.110 |
Why?
| | Osteoarthritis | 1 | 2018 | 196 | 0.110 |
Why?
| | Preoperative Care | 1 | 2018 | 379 | 0.110 |
Why?
| | Reoperation | 1 | 2018 | 630 | 0.110 |
Why?
| | Prediabetic State | 1 | 2018 | 245 | 0.110 |
Why?
| | Aspirin | 1 | 2018 | 399 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2018 | 497 | 0.100 |
Why?
| | Venous Thromboembolism | 1 | 2018 | 324 | 0.100 |
Why?
| | Anticoagulants | 1 | 2018 | 722 | 0.090 |
Why?
| | Cohort Studies | 1 | 2023 | 5960 | 0.090 |
Why?
| | Mass Screening | 1 | 2018 | 1347 | 0.070 |
Why?
| | Aged | 4 | 2022 | 25913 | 0.070 |
Why?
| | Humans | 6 | 2023 | 144759 | 0.070 |
Why?
| | Middle Aged | 4 | 2023 | 35875 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2018 | 2919 | 0.060 |
Why?
| | United States | 1 | 2022 | 15966 | 0.050 |
Why?
| | Male | 4 | 2023 | 72315 | 0.040 |
Why?
| | Aged, 80 and over | 3 | 2018 | 8265 | 0.040 |
Why?
| | Incidence | 2 | 2018 | 2879 | 0.040 |
Why?
| | Female | 4 | 2023 | 78271 | 0.040 |
Why?
| | International Normalized Ratio | 1 | 2018 | 49 | 0.030 |
Why?
| | Philadelphia | 1 | 2018 | 55 | 0.030 |
Why?
| | Tranexamic Acid | 1 | 2018 | 53 | 0.030 |
Why?
| | Elective Surgical Procedures | 1 | 2018 | 201 | 0.030 |
Why?
| | Diabetes Complications | 1 | 2018 | 222 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2018 | 779 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2018 | 194 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 2018 | 244 | 0.030 |
Why?
| | Blood Transfusion | 1 | 2018 | 405 | 0.030 |
Why?
| | Risk Factors | 2 | 2018 | 10779 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2027 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2117 | 0.020 |
Why?
| | Young Adult | 2 | 2018 | 14105 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2834 | 0.020 |
Why?
| | Adult | 3 | 2018 | 40449 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 1098 | 0.020 |
Why?
| | Blood Glucose | 1 | 2018 | 2327 | 0.020 |
Why?
| | Prospective Studies | 1 | 2018 | 7990 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2018 | 2583 | 0.010 |
Why?
|
|
Sterbis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|